InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+11.5%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Carroll J Martin, 董事. Director active across 3 companies, notably TherapeuticsMD, Inc.. Cumulatively, 15 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €38k. History available since 28 October 2021. The latest transaction was filed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Carroll J Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
177,523 股Common StockSEC:0001628280-26-048012:0
79,873 股0Common StockSEC:0001628280-26-039520:0
33,000 股0Common StockSEC:0001628280-25-028830:0
32,734 股Common StockSEC:0000950170-24-137708:0
4,663 股0Common StockSEC:0001596783-24-000101:0
23,000 股0Common StockSEC:0001628280-24-025223:0
6,993 股0Common StockSEC:0001596783-23-000159:0
555 股0Common StockSEC:0001596783-23-000044:0
5,150 股0Common StockSEC:0001628280-23-022457:0
8,409 股@ US$1.491930.4% 占其流量Common StockSEC:0001628280-23-017563:0
标准退出：2023年8月8日 (T+90)
4,149 股0Common StockSEC:0001596783-22-000163:0
5,000 股@ US$5.635969.6% 占其流量Common StockSEC:0001628280-22-016165:0
标准退出：2022年8月31日 (T+90)
3,136 股0Common StockSEC:0001596783-21-000194:0
1,402 股0Common StockSEC:0001596783-21-000169:0
96,864 股Common StockSEC:0001387131-21-008434:0
15 条申报中的 15 条
About Carroll J Martin
CARROLL J MARTIN is Administrateur at Esperion Therapeutics, Inc., Catalent, Inc. and TherapeuticsMD, Inc. Across 15 filings, the 15 sampled filings run from 2021-08-12 to 2026-07-13, with EUR 37632 of buys and EUR 0 of sells, and the most common transaction nature is Attribution.
